This wiki has undergone a migration to Confluence found Here
Difference between revisions of "PAC: FDA RFI"
Jump to navigation
Jump to search
Hbuitendijk (talk | contribs) (Created page with "Meeting announcement and survey. Survey due October 5. 10 questions, includes a question on HL7 applicability. Request RCRIM and Pharmacy to provide input") |
Hbuitendijk (talk | contribs) |
||
| Line 1: | Line 1: | ||
| − | Meeting | + | ==Introduction== |
| − | + | FDA issued a [[file:PAC FDA NoM RfC.pdf |Notice of Meeting with a Request for Comments]]. The comments are due October 5. | |
| − | 10 questions | + | |
| − | + | The 10 questions include a question on HL7 applicability, so it seems appropriate for HL7 to submit feedback to at least that question. | |
| + | |||
| + | ==Plan== | ||
| + | We wequest RCRIM and Pharmacy to provide input. Ed Tripp will coordinate. | ||
Revision as of 18:49, 13 September 2012
Introduction
FDA issued a File:PAC FDA NoM RfC.pdf. The comments are due October 5.
The 10 questions include a question on HL7 applicability, so it seems appropriate for HL7 to submit feedback to at least that question.
Plan
We wequest RCRIM and Pharmacy to provide input. Ed Tripp will coordinate.
